<?xml version="1.0" encoding="UTF-8"?>
<p>There are many problems associated with in vitro bioassays, and it will remain a problem for the normal drug discovery pipeline as well as for the reverse pharmacology approach. The only advice is to interpret in vitro results very carefully.</p>
